<DOC>
	<DOCNO>NCT02433665</DOCNO>
	<brief_summary>1 . To determine formula derive PCA use specific patient parameter use determine individual contrast material dose provide consistent level vascular parenchymal enhancement MDCT scan abdomen pelvis . 2 . Up 500 adult patient refer `` CT abdomen pelvis contrast material '' recruit participate trial . Single CT axial slice ( n=2 ) obtain level L4 pedicle supra-acetabular pelvis use field-of-view include patient . From patient measurement ( height , weight , body dimension ) , customize dose contrast material specify accord derive formula 400 subject . One hundred subject receive usual fix contrast dose . 3 . Enhancement data HU measure CT scan use manually-placed ROIs upper abdominal aorta , main portal vein liver parenchyma , avoid visible liver tumor , major blood vessel artifact , present . This enhancement data use determine patient-to-patient variability .</brief_summary>
	<brief_title>Customized Contrast Media Dose Clinical Trial</brief_title>
	<detailed_description>The next step single center , prospective clinical trial intend test hypothesis formula derive PCA use specific subject parameter use determine individual contrast material dose provide consistent level vascular parenchymal enhancement MDCT scan abdomen pelvis . 500 subject refer `` CT abdomen pelvis contrast material '' recruit participate trial . Subjects first group 200 randomize either fix dose contrast material ( 100 subject ) customize dose contrast material base experimental algorithm ( 100 subject ) . The second group 300 subject receive customize dose contrast material base experimental algorithm . All subject study single CT scanner locate Duke Cancer Center . After obtain informed consent , subject first undergo measurement height weight dedicate pair scale locate close proximity scanner . The subject place CT scan table supine position follow acquisition scout digital radiograph AP ML projection . These digital scout radiograph acquire routinely use technologist plan scan . From scout radiograph , single CT slice axial plane ( n=2 ) subsequently obtain , one level L4 pedicle supra-acetabular pelvis use field-of-view include subject . These slice part routine protocol acquire use low radiation dose parameter . From measurement ( height , weight specific body dimension ) , customize dose contrast material specify accord derive formula . Since dose different every subject , rate need adjust well . This accomplished adjusting rate injection duration every subject . For example , specify contrast material dose 100 mL injection duration 25 second , injection rate 4 mL/sec . If specify contrast material dose 125 mL injection duration also 25 second , injection rate increase 5 mL/sec . Note 100 subject receive fix dose rate ( 150 mL iopamidol concentration 300 mg iodine/mL injection rate 3 mL/sec total dose 45 gram iodine ) 400 subject administer customized dose rate ( X mL iopamidol concentration 300 mg iodine/mL injection rate X mL/sec total dose X gram iodine ) . Also note customize dose group , maximum minimum dos contrast material 200 ( 75 gm iodine ) 75 ( 22.5 gm iodine ) mL , respectively maximum minimum injection rate 6 2 mL/sec , respectively . Because injection rate customize group variable , nurse technologist establish intravenous access may choose use large small caliber angiocatheter fix group order accommodate high low injection rate , respectively . The caliber angiocatheter well venous access site record along dose rate contrast material . The rate administration contrast material control mechanical power injector furnish Nemoto Kyorindo Co , Ltd. free charge use study .</detailed_description>
	<criteria>Patients refer CT Abdomen &amp; Pelvis Contrast Material Younger 18 Pregnant Contraindication iodinate contrast material Contraindication bolus injection Indication biphasic exam ( arterial + venous phase ) Diffuse hepatic disease Subjects weigh 300 pound</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>